Stephen Van Deventer, chairman and CEO of PreveCeutical Medical Inc (CSE: PREV, OTCQB: PRVCF) and chief research officer Dr Harry Parekh discuss with Proactive the health sciences specialist's four exciting programmes.
Their most advanced is centred around Cannabidiol (CBD) - a non-psychoactive compound found in the cannabis plant and is now widely used to treat chronic pain, multiple sclerosis and other conditions.
Some evidence even suggests it can prevent symptoms of Alzheimer’s and appears to promote the death of cancer cells.
Original Article: PreveCeutical seeing significant hospital interest for breakthrough Cannabidiol treatment